Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOCARNITINE vs LEVOLEUCOVORIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOCARNITINE vs LEVOLEUCOVORIN: Safety Overview

Metric LEVOCARNITINE LEVOLEUCOVORIN
Total FAERS Reports 392 3,168
Deaths Reported 91 421
Death Rate 23.2% 13.3%
Hospitalizations 183 1,413
Average Patient Age 40.9 yrs 64.9 yrs
% Female Patients 52.6% 36.1%
FDA Approval Date Apr 10, 1986 Apr 29, 2011
Manufacturer Saptalis Pharmaceuticals, LLC Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued